{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:33Z","timestamp":1761895833039},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Hematol Blood Transfus"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12288-014-0385-1","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T11:08:24Z","timestamp":1397128104000},"page":"331-334","source":"Crossref","is-referenced-by-count":8,"title":["Coexistence of JAK2V617F Mutation and BCR\u2013ABL Translocation in a Pregnant Woman with Essential Thrombocythemia"],"prefix":"10.1007","volume":"30","author":[{"given":"You-wen","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"issue":"1","key":"385_CR1","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.leukres.2009.08.009","volume":"34","author":"G Caocci","year":"2010","unstructured":"Caocci G, Atzeni S, Orr\u00f9 N et al (2010) Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190BCR\u2013ABL oncoprotein and JAK2V617F mutation. Leuk Res 34(1):e27\u2013e29","journal-title":"Leuk Res"},{"issue":"9","key":"385_CR2","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2006-12-061135","volume":"109","author":"K Hussein","year":"2007","unstructured":"Hussein K, Bock O, Seegers A et al (2007) Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR\u2013ABL translocation and JAK2V617F mutation. Blood 109(9):4106\u20134107","journal-title":"Blood"},{"issue":"4","key":"385_CR3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s12032-010-9570-8","volume":"28","author":"G Toogeh","year":"2011","unstructured":"Toogeh G, Ferdowsi S, Naadali F et al (2011) Concomitant presence of JAK2 V617F mutation and BCR\u2013ABL translocation in a pregnant woman with polycythemia vera. Med Oncol 28(4):1555\u20131558","journal-title":"Med Oncol"},{"issue":"9464","key":"385_CR4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ et al (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365(9464):1054\u20131061","journal-title":"Lancet"},{"issue":"1","key":"385_CR5","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/ijlh.12010","volume":"35","author":"M Cappetta","year":"2013","unstructured":"Cappetta M, P\u00e9rez V, Zubillaga MN et al (2013) Concomitant detection of BCR\u2013ABL translocation and JAK2 V617F mutation in five patients with myeloproliferative neoplasm at diagnosis. Int J Lab Hematol 35(1):e4\u2013e5","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"385_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12185-008-0131-2","volume":"88","author":"MR Conchon","year":"2008","unstructured":"Conchon MR, Costa JL, Novaes MM et al (2008) Simultaneous detection of JAK2 V617F mutation and Bcr\u2013Abl translocation in a patient with chronic myelogenous leukemia. Int J Hematol 88(2):243\u2013245","journal-title":"Int J Hematol"},{"issue":"5","key":"385_CR7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.leu.2404993","volume":"22","author":"K Hussein","year":"2008","unstructured":"Hussein K, Bock O, Theophile K et al (2008) Chronic myeloproliferative diseases with concurrent BCR\u2013ABL junction and JAK2V617F mutation. Leukemia 22(5):1059\u20131062","journal-title":"Leukemia"},{"issue":"8","key":"385_CR8","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.leu.2404730","volume":"21","author":"M Bornh\u00e4user","year":"2007","unstructured":"Bornh\u00e4user M, Mohr B, Oelschlaegel U et al (2007) Concurrent JAK2(V617F) mutation and BCR\u2013ABL translocation within committed myeloid progenitors in myelofibrosis. Leukemia 21(8):1824\u20131826","journal-title":"Leukemia"},{"issue":"11","key":"385_CR9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.5858\/2007-131-1719-TOPVTC","volume":"131","author":"I Mirza","year":"2007","unstructured":"Mirza I, Frantz C, Clarke G et al (2007) Transformation of polycythemia vera to chronic myelogenous leukemia. Arch Pathol Lab Med 131(11):1719\u20131724","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"385_CR10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1470-2045(07)70295-4","volume":"8","author":"M Bocchia","year":"2007","unstructured":"Bocchia M, Vannucchi AM, Gozzetti A et al (2007) Insights into JAK2-V617F mutation in CML. Lancet Oncol 8(10):864\u2013866","journal-title":"Lancet Oncol"},{"issue":"3","key":"385_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PDM.0b013e318246975e","volume":"21","author":"JM Hummel","year":"2012","unstructured":"Hummel JM, Kletecka MC, Sanks JK et al (2012) Concomitant BCR\u2013ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms. Diagn Mol Pathol 21(3):176\u2013183","journal-title":"Diagn Mol Pathol"},{"issue":"7","key":"385_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1470-2045(07)70206-1","volume":"8","author":"A Kr\u00e4mer","year":"2007","unstructured":"Kr\u00e4mer A, Reiter A, Kruth J et al (2007) JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol 8(7):658\u2013660","journal-title":"Lancet Oncol"},{"issue":"1","key":"385_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0609.2008.01063.x","volume":"81","author":"S Pardini","year":"2008","unstructured":"Pardini S, Fozza C, Contini S et al (2008) A case of coexistence between JAK2V617F and BCR\/ABL. Eur J Haematol 81(1):75\u201376","journal-title":"Eur J Haematol"},{"issue":"12","key":"385_CR14","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/blood-2011-07-365007","volume":"118","author":"L Pieri","year":"2011","unstructured":"Pieri L, Spolverini A, Scappini B et al (2011) Concomitant occurrence of BCR\u2013ABL and JAK2V617F mutation. Blood 118(12):3445\u20133446","journal-title":"Blood"},{"issue":"5","key":"385_CR15","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.3816\/CLM.2009.n.080","volume":"9","author":"SR Pingali","year":"2009","unstructured":"Pingali SR, Mathiason MA, Lovrich SD et al (2009) Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: jAK2V617F as a potential risk factor for BCR\u2013ABL translocation. Clin Lymphoma Myeloma 9(5):E25\u2013E29","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"385_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.2010.01458.x","volume":"85","author":"A Tefferi","year":"2010","unstructured":"Tefferi A, Levitt R, Lasho TL et al (2010) Postimatinib therapy emergence of a new JAK2V617F clone and subsequent development of overt polycythemia vera in a patient with chronic myelogenous leukaemia. Eur J Haematol 85(1):86\u201387","journal-title":"Eur J Haematol"},{"issue":"10","key":"385_CR17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.leukres.2008.03.011","volume":"32","author":"A Kr\u00e4mer","year":"2008","unstructured":"Kr\u00e4mer A (2008) JAK2-V617F and BCR\u2013ABL\u2013double jeopardy? Leuk Res 32(10):1489\u20131490","journal-title":"Leuk Res"},{"issue":"5","key":"385_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ajh.21296","volume":"84","author":"S Gattenlohner","year":"2009","unstructured":"Gattenlohner S, V\u00f6lker HU, Etschmann B et al (2009) BCR\u2013ABL positive chronic myeloid leukemia with concurrent JAK2(V617F) positive myelodysplastic syndrome\/myeloproliferative neoplasm (RARS-T). Am J Hematol 84(5):306\u2013307","journal-title":"Am J Hematol"},{"issue":"1","key":"385_CR19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12185-009-0471-6","volume":"91","author":"PC Bee","year":"2010","unstructured":"Bee PC, Gan GG, Nadarajan VS et al (2010) A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders. Int J Hematol 91(1):136\u2013139","journal-title":"Int J Hematol"},{"issue":"4","key":"385_CR20","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.leukres.2009.09.025","volume":"34","author":"L V\u00e9ron\u00e8se","year":"2010","unstructured":"V\u00e9ron\u00e8se L, Tchirkov A, Richard-Pebrel C et al (2010) A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2(V617F) myeloproliferative neoplasm. Leuk Res 34(4):e94\u2013e96","journal-title":"Leuk Res"},{"issue":"7","key":"385_CR21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","volume":"22","author":"N Cambier","year":"2008","unstructured":"Cambier N, Renneville A, Cazaentre T et al (2008) JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia 22(7):1454\u20131455","journal-title":"Leukemia"},{"issue":"11","key":"385_CR22","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.leukres.2009.06.011","volume":"33","author":"L Campiotti","year":"2009","unstructured":"Campiotti L, Appio L, Solbiati F et al (2009) JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia. Leuk Res 33(11):e212\u2013e213","journal-title":"Leuk Res"},{"issue":"2","key":"385_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3960\/jslrt.52.145","volume":"52","author":"K Inokuchi","year":"2012","unstructured":"Inokuchi K, Yamaguchi H, Tamai H et al (2012) Disappearance of both the BCR\/ABL1 fusion gene and the JAK2V617F mutation with dasatinib therapy in a patient with imatinib-resistant chronic myelogenous leukemia. J Clin Exp Hematop 52(2):145\u2013147","journal-title":"J Clin Exp Hematop"},{"issue":"5","key":"385_CR24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.leu.2404591","volume":"21","author":"M Inami","year":"2007","unstructured":"Inami M, Inokuchi K, Okabe M et al (2007) Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia. Leukemia 21(5):1103\u20131104","journal-title":"Leukemia"},{"issue":"6","key":"385_CR25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.leukres.2007.10.018","volume":"32","author":"YK Kim","year":"2008","unstructured":"Kim YK, Shin MG, Kim HR et al (2008) Simultaneous occurrence of the JAK2V617F mutation and BCR\u2013ABL gene rearrangement in patients with chronic myeloproliferative disorders. Leuk Res 32(6):993\u2013995","journal-title":"Leuk Res"}],"container-title":["Indian Journal of Hematology and Blood Transfusion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12288-014-0385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12288-014-0385-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:30:02Z","timestamp":1716669002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12288-014-0385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":25,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["385"],"URL":"https:\/\/doi.org\/10.1007\/s12288-014-0385-1","relation":{},"ISSN":["0971-4502","0974-0449"],"issn-type":[{"value":"0971-4502","type":"print"},{"value":"0974-0449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}